Femasys is trading at $3.33 (6.9% down) as investors remain cautious following its recent deeply discounted equity offering and related dilution concerns.
- The stock previously plunged over 30% after the company priced a public share and warrant offering at $0.36.
- Current price action appears to reflect the market's continued digestion of the dilutive deal rather than any new company-specific headlines today.